Live Breaking News & Updates on Women Health Indications

Stay updated with breaking news from Women health indications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

11.06.2024 - Vistagen (Nasdaq: VTGN), a neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, . ....

United States , International Number Toll , Exchange Commission , B Development , Women Health Indications , Company Phase , Mental Health America Platinum Bell Seal , Fuji Pharma Co Ltd , Acute Treatment , Social Anxiety Disorder , Subjective Units , Distress Scale , Major Depressive Disorder , Key Pherine Mechanism , Positive Exploratory Phase , Data Study , Vasomotor Symptoms , Hot Flashes , Premenstrual Dysphoric Disorder , Mental Health America , Platinum Bell Seal , Cindy Anderson , Chief Financial , Exclusive Negotiation Agreement , Fuji Pharma , Fiscal Year ,

Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update

Fasedienol PALISADE Phase 3 program for the acute treatment of social anxiety disorder remains on trackPALISADE-3 trial initiation anticipated in 1H 2024; PALISADE-4 trial initiation anticipated in 2H 2024SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) $VTGN #mentalhealth Vistagen (Nasdaq: VTGN), a late clinical-stag. ....

United States , Shawn Singh , Marka Mcpartland , Company Phase , Company Quarterly Report On Form , International Number Toll , Women Health Indications , Exchange Commission , Chief Executive Officer , Nasal Spray , Acute Treatment , Social Anxiety Disorder , Subjective Units , Distress Scale , Drug Application , Major Depressive Disorder , Vasomotor Symptoms , Hot Flashes , Quarter Financial , Dial In Number , Annual Report , Quarterly Report ,